Orthopedics
News, opinions and meeting coverage in surgery.
<ѻýҕl>Medtronic's Infuse Moves From Operating Room to Courtroomѻýҕl>
An investigative series by ѻýҕl/Milwaukee Journal Sentinel has been tracking the spinal fusion device called Infuse in a 4-year-long series and now reports how a flawed FDA system for device approval may have led to a long string of adverse events culminating in thousands of liability suits.
May 18, 2014
<ѻýҕl>Mixed Results for Metal Ions Test in MoM Hipsѻýҕl>
CHICAGO -- Measurement of metal ion levels in whole blood in patients with metal-on-metal hip implants is useful, but imperfect, for identifying those whose new hips are functioning poorly and may be likely to fail, a researcher said here.
Mar 21, 2013
<ѻýҕl>Spine Fusion Device Ignites Academic Feudѻýҕl>
Responding to a series of studies linking Medtronic's bone morphogenetic protein-2 product to a number of serious adverse events, a leading BMP-2 researcher is taking the offensive by taking aim at his critics in a manner that some observers say goes too far. This latest report in an ongoing Milwaukee Journal Sentinel/ѻýҕl series details the claims and counterclaims.
Jul 07, 2011
<ѻýҕl>Researcher Sounded Alarm on Medtronic's Infuse Years Agoѻýҕl>
As part of a continuing investigation into a bone morphogenetic protein-2 product marketed as Infuse, the Milwaukee Journal Sentinel/ѻýҕl describe a first-hand account of early signs of problems with the device as well as efforts to minimize the clinical significance of those problems.
Jun 28, 2011